Contrasting Brainchip (OTCMKTS:BRCHF) and ChronoScale Corporation Common Stock (NASDAQ:CHRN)

ChronoScale Corporation Common Stock (NASDAQ:CHRN) and Brainchip (OTCMKTS:BRCHF) are both small-cap technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares ChronoScale Corporation Common Stock and Brainchip’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ChronoScale Corporation Common Stock	-135.66%	-197.81%	-74.17%
Brainchip	N/A	N/A	N/A

Risk and Volatility

ChronoScale Corporation Common Stock has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Brainchip has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for ChronoScale Corporation Common Stock and Brainchip, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ChronoScale Corporation Common Stock	1	1	0	0	1.50
Brainchip	0	0	0	0	0.00

ChronoScale Corporation Common Stock currently has a consensus price target of $6.00, suggesting a potential downside of 74.83%. Given ChronoScale Corporation Common Stock’s stronger consensus rating and higher probable upside, equities research analysts clearly believe ChronoScale Corporation Common Stock is more favorable than Brainchip.

Earnings & Valuation

This table compares ChronoScale Corporation Common Stock and Brainchip”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ChronoScale Corporation Common Stock	$12.80 million	6.63	-$11.69 million	($5.38)	-4.43
Brainchip	$400,000.00	541.79	N/A	N/A	N/A

Brainchip has lower revenue, but higher earnings than ChronoScale Corporation Common Stock.

Insider and Institutional Ownership

6.4% of ChronoScale Corporation Common Stock shares are owned by institutional investors. 6.9% of ChronoScale Corporation Common Stock shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

About Brainchip

BrainChip Holdings Ltd develops software and hardware accelerated solutions for artificial intelligence and machine learning applications in North America, Oceania, Europe, the Middle East, and Asia. The company primarily focuses on development of Akida Neuromorphic Processor to provide ultra-low power and fast AI Edge Network for vision, audio, olfactory, and smart transducer applications. It also offers Akida IP, a neural processor; MetaTF, which is used for creation, training, and testing of neutral network; Akida enablement platforms, including Akida PCI, Edge AI box, and development kit and shuttle PC and raspberry Pi; AKD1000, a reference chip as a hardware accelerator; and 2nd generation akidaTM expands the benefits of event-based, neuromorphic processing for network models. In addition, the company provides MetaTF ML framework python packages, which includes Akida python package, an interface to the BrainChip Akida Neuromorphic System-on-Chip; CNN2SNN tool provides means to convert convolutional neural networks; and the Akida model zoo, a pre-created network models built with the Akida sequential API and the CNN2SNN tool using quantized Keras models. Its products are used for original equipment manufacturer, end users, and system integrators based on artificial neural networks. The company was formerly known as Aziana Limited. BrainChip Holdings Ltd was incorporated in 2011 and is based in Sydney, Australia.